Barrow, Hanley, Mewhinney & Strauss’s Nu Skin NUS Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-53	Closed	-$365	–	341
2024 Q4	$365	Hold	53	–	–	﹤0.01%	323
2024 Q3	$391	Buy	53 +3	+6%	+$28	﹤0.01%	324
2024 Q2	$527	Buy	+50	New	+$634	﹤0.01%	296
2021 Q4	–	Sell	-432	Closed	-$17K	–	358
2021 Q3	$17K	Buy	+432	New	+$21.9K	﹤0.01%	303
2018 Q4	–	Sell	-236	Closed	-$19K	–	384
2018 Q3	$19K	Hold	236	–	–	﹤0.01%	353
2018 Q2	$18K	Sell	236 -106	-31%	-$8.21K	﹤0.01%	361
2018 Q1	$25K	Hold	342	–	–	﹤0.01%	388
2017 Q4	$23K	Hold	342	–	–	﹤0.01%	390
2017 Q3	$21K	Hold	342	–	–	﹤0.01%	403
2017 Q2	$21K	Hold	342	–	–	﹤0.01%	404
2017 Q1	$19K	Buy	+342	New	+$17.6K	﹤0.01%	404

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's NUS Position: Q1 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 53 shares — an estimated $365 sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NUS in Q1 2017 and held it in 11 quarters. The position peaked at $25K in Q1 2018. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

Barrow, Hanley, Mewhinney & Strauss reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
Barrow, Hanley, Mewhinney & Strauss sold 53 Nu Skin shares in Q1 2025, an estimated $365.
Barrow, Hanley, Mewhinney & Strauss first reported a position in Nu Skin in Q1 2017 and held it in 11 quarters.
Barrow, Hanley, Mewhinney & Strauss's Nu Skin position peaked at $25K in Q1 2018.
195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2025, filed 12 May 2025.